Drugging the foam cell: identifying P2Y6 antagonists that limit atherosclerosis

Eur Heart J. 2024 Jan 27;45(4):284-286. doi: 10.1093/eurheartj/ehad846.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Atherosclerosis* / drug therapy
  • Atherosclerosis* / metabolism
  • Calcium* / metabolism
  • Calreticulin / metabolism
  • Foam Cells / metabolism
  • Humans
  • Macrophages / metabolism
  • Phospholipases / metabolism
  • Receptors, Purinergic P2*
  • Receptors, Scavenger / metabolism

Substances

  • purinoceptor P2Y6
  • Calcium
  • Calreticulin
  • Receptors, Scavenger
  • Phospholipases
  • Receptors, Purinergic P2